Study Shows CAR T-Cell Therapy Is Effective at Putting Childhood Leukemia Into Remission
A study from China published in the Journal of Clinical Oncology has shown that CAR T-cell therapy that targets CD19 and CD22 is effective at treating recurrent or refractory acute lymphoblastic leukemia in children.